GLAXF
GSK PLC
stockOTC
we are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. as one of the few healthcare companies researching both medicines and vaccines for the world health organization's three priority diseases – hiv/aids, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. our product portfolio also includes a range of consumer brands, many of which are household names around the world, including sensodyne, aquafresh, horlicks, panadol and tums.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 24.00 | 2026-09-28 | -5.13% | 0.000 |
| 1M | 25.21 | 2026-09-04 | -9.66% | -2.746 |
| 3M | 25.77 | 2026-07-02 | -11.64% | -1.281 |
| 6M | 26.55 | 2026-04-06 | -14.24% | -0.200 |
| 1Y | 21.68 | 2025-10-03 | +5.05% | -0.182 |
| 2Y | 19.52 | 2024-10-04 | +16.65% | — |
| 5Y | 23.69 | 2021-10-04 | -3.89% | 0.103 |
GSK PLC (OTC:GLAXF) stock price today is $22.77, and today's volume is 1,100. GLAXF is down 5.125% today. The 30 day average volume is 1,378. GLAXF market cap is $94.38B with 4.15B shares outstanding.